y 27632 has been researched along with chlorpropamide in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (chlorpropamide) | Trials (chlorpropamide) | Recent Studies (post-2010) (chlorpropamide) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 1,888 | 101 | 63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houghton, PJ; Shu, L | 1 |
1 other study(ies) available for y 27632 and chlorpropamide
| Article | Year |
|---|---|
The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.
Topics: Adaptor Proteins, Signal Transducing; Amides; Animals; Antibiotics, Antineoplastic; Carrier Proteins; Cell Differentiation; Cell Line; Chlorpropamide; Enzyme Inhibitors; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Muscle Development; Muscle, Skeletal; Myoblasts; Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; rho-Associated Kinases; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2009 |